Purchases and Sales Made in Q4 2021 in Rubius Therapeutics, Inc. (RUBY)
This table provides information about the institutional ownership of Rubius Therapeutics, Inc. (RUBY) during Q4 2021. The information is specifically focused on institutions that hold shares of Rubius Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
SELL
|
- |
-46.1KClosed |
$446K - $817K
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-66KClosed |
$639K - $1.17M
|
0
$0
|
|
|
Feb 14, 2022
Q4 2021
|
State Street Corp
Boston, MA |
SELL
|
- |
-187K- 7.93% |
$1.81M - $3.31M
|
2.17M
$0
|
|
|
Feb 11, 2022
Q4 2021
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-454K- 10.93% |
$4.4M - $8.05M
|
3.7M
$0
|
|
|
Feb 14, 2022
Q4 2021
|
Arch Venture Management, LLC
Chicago, IL |
SELL
|
- |
-2.27M- 86.64% |
$22M - $40.2M
|
350K
$0
|